Statins increase risk of diabetes in Caucasian men
the ONA take:
According to new research published in the journal Diabetologia, researchers from Finland have found that statin use is associated with an increased risk of developing diabetes.
In the study, researchers analyzed data from 8,749 non-diabetic men in a 6-year follow-up of the population-based Metabolic Syndrome in Men (METSIM) study in Finland.
The participants ranged in age from 45 to 73 years and were followed for 5.9 years. Of those men, 625 were diagnosed with new diabetes during the follow-up period.
Results showed that after adjusting for confounding factors, patients treated with statins were 46% more likely to develop diabetes compared with those non treated with statins. In addition, researchers found that the risk was dose-dependent for atorvastatin and simvastatin.
The authors suggest that the association between statin use and increased risk for diabetes is most likely due to statins decreasing both insulin sensitivity and insulin secretion.
Although the findings are reliable, the study only included Caucasian men and therefore should not be applied to women or people of other ethnic origin without further research.
Statin use is associated with an increased risk of developing diabetes.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
- Arsenic Pretreatment May Protect Normal Tissue During Chemo in Breast Cancer
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|